RecruitingPhase 4NCT07219121
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Studying Nephrotic syndrome without extrarenal manifestations
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Travere Therapeutics, Inc.
- Principal Investigator
- Radko Komers, MD, PhDTravere Therapeutics
- Intervention
- Sparsentan(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2027
Study locations (9)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Cornell Medical Center, New York, New York, United States
- University of North Carolina Chapel Hill, Morrisville, North Carolina, United States
- Ohio State University, Columbus, Ohio, United States
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
- Dallas Nephrology Associates, Dallas, Texas, United States
- University of Texas, Galveston, Texas, United States
- University of Washington, Seattle, Washington, United States
- University of Wisconsin, Madison, Wisconsin, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07219121 on ClinicalTrials.govOther trials for Nephrotic syndrome without extrarenal manifestations
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07267026A Study to Evaluate the Safety, Tolerability and PK of SK-09Consun Pharmaceutical Group
- RECRUITINGNANCT06867471Effects of Exogenous Ketosis on Proteinuria and Renal FunctionGødstrup Hospital
- RECRUITINGPHASE3NCT05716880Ketoanalogues for Muscle Mass Loss in Nephrotic SyndromeMilitary Institute od Medicine National Research Institute
- RECRUITINGPHASE2NCT05003986Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular DiseasesTravere Therapeutics, Inc.
- RECRUITINGNCT01209000Nephrotic Syndrome Study NetworkUniversity of Michigan
- RECRUITINGNCT01094327Proteinuria in Pre and Post TransplantUniversity of Miami
See all trials for Nephrotic syndrome without extrarenal manifestations →